About Us

Discover Our Story

“It's a good idea to fall in love with the problem you're solving. That's exactly what happened at Shifamed. They faced a major challenge. How do I innovate fast but also stay compliant? That's how they came up with Enlil and why they built it.”

– Nader Fathi, Enlil CEO

our mission

To be the backbone that powers MedTech innovation. With our purpose-built, intelligent platform, Enlil unifies design manufacturing and compliance into one, scalable solution.

Our expertise is grounded not just in regulatory theory but in real-world needs, thanks to our close collaboration with the Shifamed portfolio of companies. This connection gives us direct, ongoing insight into the pain points, priorities, and pace of MedTech innovators, ensuring that our platform evolves in step with the industry we serve

timeline

November 2019

Enlil Founded in order to address the evolving needs of the MedTech industry.

December 2020

Adoption of Enlil begins across the Shifamed portfolio.

May 2021

Enlil raises $2,000,000 in seed round.

July 2022

Introduction of Procurement and  Supplier Management.

August 2023

Enlil incorporates Requirements Management Module and Trace and  Risk Matrix.

November 2024

Enlil unveiled to public at MEDevice Silicon Valley 2024.

September 2025

Enlil revolutionizes the MedTech Regulatory Submissions Process with its innovative Agentic AI.

Team

The Minds Behind the Mission

"These are industry vets who've come out of what great looks like."
– Joe Mullings, Founder, Chairman, and CEO of the Mullings Group

Our powerhouse team combines deep expertise in PLM, QMS, ERP, and cutting-edge software with a passion for leveraging technology to transform life sciences product development. We partner with industry visionaries to drive innovations that improve patient outcomes and redefine what’s possible in the market.